Evaluation of Sofosbuvir (β-D-2′-deoxy-2′-α-fluoro-2′-β-C-methyluridine) as an inhibitor of Dengue virus replication(#)

Documenti analoghi

• The Mechanism of Action of β-d-2′-Deoxy-2′-Fluoro-2′-C-Methylcytidine Involves a Second Metabolic Pathway Leading to β-d-2′-Deoxy-2′-Fluoro-2′-C-Methyluridine 5′-Triphosphate, a Potent Inhibitor of the Hepatitis C Virus RNA-Dependent RNA Polymerase
  di: Murakami, Eisuke, et al.
  Pubblicazione: (2008)
• Synthesis and anti-HCV activity of β-d-2′-deoxy-2′-α-chloro-2′-β-fluoro and β-d-2′-deoxy-2′-α-bromo-2′-β-fluoro nucleosides and their phosphoramidate prodrugs
  di: Ovadia, Reuben, et al.
  Pubblicazione: (2019)
• PSI-7851, a Pronucleotide of β-d-2′-Deoxy-2′-Fluoro-2′-C-Methyluridine Monophosphate, Is a Potent and Pan-Genotype Inhibitor of Hepatitis C Virus Replication
  di: Lam, Angela M., et al.
  Pubblicazione: (2010)
• Identification of a Pyridoxine-Derived Small-Molecule Inhibitor Targeting Dengue Virus RNA-Dependent RNA Polymerase
  di: Xu, Hong-Tao, et al.
  Pubblicazione: (2015)
• The Crystal and Molecular Structure of 5-Fluoro-2′-Deoxy-β-Uridine
  di: Harris, David R., et al.
  Pubblicazione: (1964)